Patents by Inventor Rong-Ming Lyu
Rong-Ming Lyu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20210061893Abstract: Human phoenixin peptides, analogs and mimetics useful in production of anti-phoenixin antibodies, diagnostic screening and assays, and in modulating cellular concentration of cAMP, and treatment of disorders related to cAMP or Ca2+ concentration in cells, modulating hypertension and cardiovascular function, modulating gonadotrophs and gastric emptying.Type: ApplicationFiled: November 4, 2020Publication date: March 4, 2021Applicant: Phoenix Pharmaceuticals, Inc.Inventors: Jaw-Kang Chang, Rong-Ming Lyu
-
Patent number: 10836812Abstract: Human phoenixin peptides, analogs and mimetics useful in production of anti-phoenixin antibodies, diagnostic screening and assays, and in modulating cellular concentration of cAMP, and treatment of disorders related to cAMP or Ca2+ concentration in cells, modulating hypertension and cardiovascular function, modulating gonadotrophs and gastric emptying.Type: GrantFiled: January 2, 2017Date of Patent: November 17, 2020Assignee: Phoenix Pharmaceuticals, Inc.Inventors: Jaw-Kang Chang, Rong-Ming Lyu
-
Publication number: 20170145083Abstract: Human phoenixin peptides, analogs and mimetics useful in production of anti-phoenixin antibodies, diagnostic screening and assays, and in modulating cellular concentration of cAMP, and treatment of disorders related to cAMP or Ca2+ concentration in cells, modulating hypertension and cardiovascular function, modulating gonadotrophs and gastric emptying.Type: ApplicationFiled: January 2, 2017Publication date: May 25, 2017Applicant: Phoenix Pharmaceuticals, Inc.Inventors: Jaw-Kang Chang, Rong-Ming Lyu
-
Patent number: 9534045Abstract: Human phoenixin peptides, analogs and mimetics useful in production of anti-phoenixin antibodies, diagnostic screening and assays, and in modulating cellular concentration of cAMP, and treatment of disorders related to cAMP or Ca2+ concentration in cells, modulating hypertension and cardiovascular function, modulating gonadotrophs and gastric emptying.Type: GrantFiled: April 27, 2015Date of Patent: January 3, 2017Assignee: Phoenix Pharmaceuticals, Inc.Inventors: Jaw-Kang Chang, Rong-Ming Lyu
-
Publication number: 20150322141Abstract: Human phoenixin peptides, analogs and mimetics useful in production of anti-phoenixin antibodies, diagnostic screening and assays, and in modulating cellular concentration of cAMP, and treatment of disorders related to cAMP or Ca2+ concentration in cells, modulating hypertension and cardiovascular function, modulating gonadotrophs and gastric emptying.Type: ApplicationFiled: April 27, 2015Publication date: November 12, 2015Applicant: Phoenix Pharmaceuticals, Inc.Inventors: Jaw-Kang Chang, Rong-Ming Lyu
-
Patent number: 9018350Abstract: Human phoenixin peptides, analogs and mimetics useful in production of anti-phoenixin antibodies, diagnostic screening and assays, and in modulating cellular concentration of cAMP, and treatment of disorders related to cAMP or Ca2+ concentration in cells, modulating hypertension and cardiovascular function, modulating gonadotrophs and gastric emptying.Type: GrantFiled: May 25, 2012Date of Patent: April 28, 2015Assignee: Phoenix Pharmaceuticals, Inc.Inventors: Jaw-Kang Chang, Rong-Ming Lyu
-
Publication number: 20140163202Abstract: Human phoenixin peptides, analogs and mimetics useful in production of anti-phoenixin antibodies, diagnostic screening and assays, and in modulating cellular concentration of cAMP, and treatment of disorders related to cAMP or Ca2+ concentration in cells, modulating hypertension and cardiovascular function, modulating gonadotrophs and gastric emptying.Type: ApplicationFiled: May 25, 2012Publication date: June 12, 2014Applicant: Phoenix Pharmaceuticals, Inc.Inventors: Jaw-Kang Chang, Rong-Ming Lyu
-
Publication number: 20080124813Abstract: A method of small volume bead-based radioimmunoassay which includes utilization of an immunoassay particle having a solid phase substrate linked to a target particle capture moiety which dissociably captures target particles in an immunoassay sample. Specifically, a bead linked to antibody which competitively dissociably captures target particles and labeled particles of an immunoassay sample in a small volume bead-based radioimmunoassay to allow determination of the concentration of target particles, the level of protease activity, or the level of protease inhibitor activity in such immunoassay samples.Type: ApplicationFiled: November 17, 2007Publication date: May 29, 2008Inventors: Jaw-Kang Chang, Rong Ming Lyu
-
Patent number: 6958162Abstract: Pharmaceutical compositions for treating immunological disorders and the preparing method of the same are disclosed, which include alcohol extracts of Radix Dioscorea, Rhizoma Alismatis, Poria cocos (schw) Wolf, and Scutellaria Baicalensis. The compositions are manufactured by novel procedures consisting of decocting using specific concentration ranges of alcohol, filtering, regulating pH value, purifying, concentrating, proportionally mixing, and making a granule powder from lyophilized extract. This invention used both in vitro and in vivo assays to evaluate therapeutic effects of specific combination of herbal plant extracts. The combination of herbal extracts has been able to maximize the anti-inflammatory activity and regulate the secretion of cytokines such as eotaxin and IL-4.Type: GrantFiled: June 30, 2003Date of Patent: October 25, 2005Assignee: Industrial Technology Research InstituteInventors: Rong-Ming Lyu, I-Hong Pan, Jir-mehng Lo, Sue-Fen Jiang, Sheau-Ni Su, Nai-Yun Hsu, Shih Cheng Shen, Hsin-Chieh Wu, Lain-Tze Lee, Yih-Loong Lai, Jaw-Ji Tsai
-
Publication number: 20040265402Abstract: Pharmaceutical compositions for treating immunological disorders and the preparing method of the same are disclosed, which include alcohol extracts of Radix Dioscorea, Rhizoma Alismatis, Poria cocos (schw) Wolf, and Scutellaria Baicalensis. The compositions are manufactured by novel procedures consisting of decocting using specific concentration ranges of alcohol, filtering, regulating pH value, purifying, concentrating, proportionally mixing, and making a granule powder from lyophilized extract. This invention used both in vitro and in vivo assays to evaluate therapeutic effects of specific combination of herbal plant extracts. The combination of herbal extracts has been able to maximize the anti-inflammatory activity and regulate the secretion of cytokines such as eotaxin and IL-4.Type: ApplicationFiled: June 30, 2003Publication date: December 30, 2004Applicant: Industrial Technology Research InstituteInventors: Rong-Ming Lyu, I-Hong Pan, Jir-mehng Lo, Sue-Fen Jiang, Sheau-Ni Su, Nai-Yun Hsu, Shih Cheng Shen, Hsin-Chieh Wu, Lain-Tze Lee, Yih-Loong Lai, Jaw-Ji Tsai